These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2953160)

  • 1. The MPA test: a reevaluation.
    Dei M; Lippi G; Pasquini MG; Guerrera A; Bruni V
    Acta Eur Fertil; 1986; 17(5):349-52. PubMed ID: 2953160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
    Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
    Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
    Boschitsch E; Gitsch E; Spona J
    Wien Klin Wochenschr; 1983 Oct; 95(20):718-24. PubMed ID: 6229096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate.
    Blossey HC; Wander HE; Koebberling J; Nagel GA
    Cancer; 1984 Sep; 54(6 Suppl):1208-15. PubMed ID: 6088020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine assessment of post-pill amenorrhoea.
    Newton J; Curson R
    Proc R Soc Med; 1973 Jun; 66(6):567-9. PubMed ID: 4592764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
    Bernardi F; Pluchino N; Pieri M; Begliuomini S; Lenzi E; Puccetti S; Casarosa E; Luisi M; Genazzani AR
    Neuroendocrinology; 2006; 83(5-6):348-59. PubMed ID: 16931878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose medroxyprogesterone acetate and various other steroid hormones on plasma membrane lipid mobility in CAMA-1 mammary cancer cells.
    Van Bömmel T; Marsen T; Bojar H
    Anticancer Res; 1987; 7(6):1217-23. PubMed ID: 2964808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
    Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A
    J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of GnRH response by clomiphene citrate.
    Goerzen J; Corenblum B; Taylor PJ
    J Reprod Med; 1985 Oct; 30(10):749-52. PubMed ID: 3934371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of every-other-day administration of gonadotropin-releasing hormone in women with hypothalamic amenorrhea: gonadotropin-releasing hormone treatment can induce clomiphene responsiveness.
    Kotsuji F; Aso T; Kamitani N; Tominaga T; Kitaguchi M; Okamura Y
    Obstet Gynecol; 1988 Apr; 71(4):615-21. PubMed ID: 3281077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arginine-GnRH-TRH test in patients with primary hypothalamic amenorrhea].
    Rudolf K; Kunkel S; Sudik R; Rüting M; Rohde E
    Zentralbl Gynakol; 1985; 107(16):996-1002. PubMed ID: 3931389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women.
    Tepper R; Bar J; Goldberger S; Fuchs J; Beyth Y; Ovadia J
    Maturitas; 1996 May; 24(1-2):51-6. PubMed ID: 8794434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones.
    Kastin AJ; Gual C; Schally AV
    Recent Prog Horm Res; 1972; 28():201-27. PubMed ID: 4569230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen provocation test as a supplement to the gonadotropin-releasing hormone test in secondary amenorrhea].
    Mazzi C
    Akush Ginekol (Sofiia); 1980; 19(5-6):541-3. PubMed ID: 6784590
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of synthetic gonadotropin-releasing hormone on the secretion of a luteinizing hormone (LH) and total estrogens in secondary amenorrhea].
    Gigon U; Keller H; Stamm O
    Gynakol Rundsch; 1973; 13(4):297-306. PubMed ID: 4594495
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of clomiphene and raloxifene on gonadotrophin secretion in postmenopausal women: evidence of nongenomic action.
    Garas A; Trypsianis G; Kallitsaris A; Milingos S; Messinis IE
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):256-62. PubMed ID: 15272923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.